MEGAVOG 0.2MG TABLET 30'S
By ARISTO PHARMACEUTICALS PRIVATE LIMITED
Contains: VOGLIBOSE 0.2 MG
About MEGAVOG 0.2MG TABLET 30'S
- MEGAVOG 0.2MG TABLET 30'S is a prescription medicine that belongs to the class of drugs known as alpha-glucosidase inhibitors. It is primarily used to control high blood sugar levels in patients with type 2 diabetes mellitus.
- The medication works by inhibiting the action of enzymes in the small intestine that break down carbohydrates and sugars. This slows down the digestion and absorption of carbohydrates and sugars, leading to a slower and more gradual rise in blood sugar levels after a meal.
- MEGAVOG 0.2MG TABLET 30'S is usually taken with the first bite of each main meal. The dosage and frequency of the medication depend on the patient's age, medical history, and response to treatment. It is essential to follow the doctor's instructions carefully and not to exceed the prescribed dose.
- Common side effects of MEGAVOG 0.2MG TABLET 30'S include flatulence, abdominal discomfort, diarrhea, and nausea. These side effects are usually mild and go away on their own after a few days of treatment. If the side effects persist or worsen, it is important to inform the doctor immediately.
- MEGAVOG 0.2MG TABLET 30'S is not recommended for patients with a history of intestinal obstruction, chronic digestive disorders, or kidney or liver disease. It should also be used with caution in patients taking insulin or other blood sugar-lowering medications.
- In conclusion, MEGAVOG 0.2MG TABLET 30'S is a prescription medication used to control high blood sugar levels in patients with type 2 diabetes mellitus. It works by slowing down the digestion and absorption of carbohydrates and sugars. While the medication is generally safe and effective, it is important to follow the doctor's instructions carefully and report any side effects or concerns.
Uses of MEGAVOG 0.2MG TABLET 30'S
- Is used to treat 2 Types of Diabetes
- prevents from the development of 2 diabetes
- Is used to treat Postprandial Hyperglycemia
How MEGAVOG 0.2MG TABLET 30'S Works
- MEGAVOG 0.2MG TABLET 30'S slows down digestion and absorption of carbohydrates and sugars, resulting in a more gradual rise in blood sugar levels after meals.
- Normally, after a meal, carbohydrates and sugars are broken down into simple sugars such as glucose. The glucose is then absorbed into the bloodstream, causing an increase in blood sugar levels. In patients with type 2 diabetes mellitus, this increase in blood sugar levels is more significant due to insulin resistance or insufficient insulin production.
- MEGAVOG 0.2MG TABLET 30'S blocks the enzymes that break down carbohydrates and sugars, delaying their absorption into the bloodstream. As a result, there is a slower and more gradual rise in blood sugar levels after a meal. This helps to control blood sugar levels and prevent the spikes in blood sugar that can occur in patients with type 2 diabetes mellitus.
Dosage of MEGAVOG 0.2MG TABLET 30'S Works
- For Children: The dosage of MEGAVOG 0.2MG TABLET 30'S for children is not established and should be determined by a pediatrician or endocrinologist based on individual factors such as age, weight, and medical history. It is important to follow the doctor's instructions regarding dosage and timing of medication. MEGAVOG 0.2MG TABLET 30'S is typically not recommended for use in children under the age of 18.
- For adults: The usual dose of MEGAVOG 0.2MG TABLET 30'S for adults is one tablet taken orally three times a day, immediately before each main meal. The dosage may be adjusted by your doctor based on your blood sugar levels and response to treatment. It is important to follow your doctor's instructions regarding dosage and timing of medication. Do not exceed the recommended dose and do not stop taking the medication without consulting your healthcare provider.
Side Effects Of MEGAVOG 0.2MG TABLET 30'S
- Flatulence
- Abdominal bloating
- Diarrhea
- Stomach discomfort
- Nausea
- Vomiting
How to Store MEGAVOG 0.2MG TABLET 30'S
- Store MEGAVOG 0.2MG TABLET 30'S at room temperature, between 15°C to 30°C (59°F to 86°F).
- Keep the medication in its original packaging until you are ready to use it.
- Do not expose MEGAVOG 0.2MG TABLET 30'S to excessive heat, moisture, or direct sunlight.
- Keep MEGAVOG 0.2MG TABLET 30'S out of reach of children and pets.
Frequently asked questions about MEGAVOG 0.2MG TABLET 30'S
MEGAVOG 0.2MG TABLET 30'S is used to treat type 2 diabetes mellitus in adults.
MEGAVOG 0.2MG TABLET 30'S works by increasing the release of insulin from the pancreas and reducing the production of glucose by the liver.
MEGAVOG 0.2MG TABLET 30'S should be taken orally, with or without food, as directed by your healthcare professional.
If you miss a dose of Advog 0.2mg Tablet, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the scheduled time.
The possible side effects of MEGAVOG 0.2MG TABLET 30'S include hypoglycemia (low blood sugar), gastrointestinal side effects such as diarrhea and stomach discomfort, and allergic reactions. Consult your healthcare professional if you experience any side effects.
MEGAVOG 0.2MG TABLET 30'S should not be used during pregnancy or breastfeeding unless absolutely necessary. Consult your healthcare professional before taking the medication.
If you experience symptoms of hypoglycemia such as dizziness, sweating, or confusion, consume a quick source of sugar such as a glucose tablet, fruit juice, or candy. Consult your healthcare professional if you experience frequent episodes of hypoglycemia.
Drinking alcohol can increase the risk of hypoglycemia, so it is recommended to limit or avoid alcohol consumption while taking Advog 0.2mg Tablet.
MEGAVOG 0.2MG TABLET 30'S may interact with other medications, so it is important to inform your healthcare professional about all medications you are taking before starting the medication.
References related to MEGAVOG 0.2MG TABLET 30'S
- Voglibose: An Alpha Glucosidase Inhibitor. (2013). JOURNAL of CLINICAL and DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2013/6373.3838
- Pattanaik, S. R., Shah, P., Baker, A., Sinha, N., Kumar, N., & Swami, O. C. (2018). Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus. JOURNAL of CLINICAL and DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2018/32803.11399
- JCDR -. (2018). Retrieved May 12, 2023, from Jcdr.net website: https://www.jcdr.net/article_fulltext.asp?id=3838
Harendra Kumawat
Show More
Reviewed on 14 Sep 2023
Harendra Kumawat
Reviewed on 14 Sep 2023
I recently had a great experience with Medkart Pharmacy and wanted to share my positive review. The Show More
shashiprakash sharma
Reviewed on 20 Aug 2023
shashiprakash sharma
Reviewed on 20 Aug 2023
Good pharmacy
Bored as hell
Reviewed on 30 Dec 2022
Bored as hell
Reviewed on 30 Dec 2022
Very great service
Naval Kava
Reviewed on 01 Apr 2024
Naval Kava
Reviewed on 01 Apr 2024
Interactive and knowledgeable
Tarun Ezava
Show More
Reviewed on 22 Jun 2023
Tarun Ezava
Reviewed on 22 Jun 2023
Awesome experience every time i get medicine on time and they have delivery on time also staff are v Show More